alendronate has been researched along with tyrosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikebuchi, Y; Kawagishi, R; Morishige, K; Murata, Y; Sawada, K; Tahara, M; Tasaka, K | 1 |
| Chellaiah, MA; Schaller, MD | 1 |
| Graham, B; Hübner, R; Joshi, T; Kubeil, M; Nsubuga, A; Sgarzi, M; Stephan, H; Steudtner, R; Zarschler, K | 1 |
3 other study(ies) available for alendronate and tyrosine
| Article | Year |
|---|---|
Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.
Topics: Alendronate; Cell Movement; Cell Survival; Cytoskeletal Proteins; Diterpenes; Drug Interactions; Enzyme Activation; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysophospholipids; Myosin Light Chains; Ovarian Neoplasms; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; rho GTP-Binding Proteins; Tumor Cells, Cultured; Tyrosine | 2002 |
Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro.
Topics: Actin-Related Protein 2; Alendronate; Animals; Bone Density Conservation Agents; Cortactin; Diphosphonates; Enzyme Activation; Humans; Mice; Mice, Inbred C57BL; Osteoclasts; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 12; Protein Tyrosine Phosphatases; Recombinant Fusion Proteins; RNA, Small Interfering; src-Family Kinases; Tyrosine; Wiskott-Aldrich Syndrome Protein | 2009 |
Facile preparation of multifunctionalisable 'stealth' upconverting nanoparticles for biomedical applications.
Topics: Alendronate; Amines; Biomedical Engineering; Fluorides; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Ligands; Luminescence; Nanoparticles; Nanotechnology; Polyethylene Glycols; Serum; Surface Properties; Tyrosine; Water; Yttrium | 2018 |